Radiopharm completes enrolment for brain metastases trial
Radiopharm Theranostics (ASX:RAD) announced the completion of enrolment for its US Phase 2b imaging trial of RAD 101.
Every story in this category, newest first.
Radiopharm Theranostics (ASX:RAD) announced the completion of enrolment for its US Phase 2b imaging trial of RAD 101.
Flight Centre Travel (ASX:FLT) finalised its $200 million on-market share buy-back programme.
Bloomberg's Michael Heath breaks down the strong rhetoric coming from both the US and Iranian side over the Strait of Hormuz closure, and discusses the likelihood of negotiations resuming.
Netwealth Group (ASX:NWL) reported a robust performance for the period ended March 31, with total funds under administration of $125.8 billion.
PowerPlus Energy has been awarded a $2.3 million grant by the Australian Renewable Energy Agency.
Pilbara Minerals (ASX:PLS) has priced an upsized US$600 million offering of senior unsecured notes.
AMP (ASX:AMP) reported a strong Q1 with a 45% surge in platforms net cashflows to $1.1 billion.
Fletcher Building (ASX:FBU) has released its Q3 FY26 quarterly volume report, revealing a landscape of tentative recovery.
Defence Minister Richard Marles is set to announce a monumental $53 billion boost to Australia's military coffers over the next decade.
Triton Minerals (ASX:TON) announced a breakthrough at its Aucu Gold-Copper Project in Mozambique's Tete Province.
Emergency crews remain on high alert as a catastrophic blaze continues to engulf the Viva Energy (ASX:VEA) refinery in Geelong.
The Albanese government finds itself at a policy crossroads as internal divisions emerge over a proposed profit-based gas tax.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy